Friday, November 6, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Kayla Weiss Miranda, MD

Kayla Weiss Miranda, MD

Baylor College of Medicine

Kayla Weiss Miranda, MD is a medical oncologist specializing in gastrointestinal malignancies at the Michael E. DeBakey VA Medical Center in Houston and an Assistant Professor at Baylor College of Medicine. Dr. Miranda earned a medical degree from the University of Texas Medical Branch, completed internal medicine training at Vanderbilt University, and completed a hematology/oncology fellowship at Baylor College of Medicine, where she served as chief fellow. Clinical and research interests include GI cancer survivorship, supportive care, and medical education, with research presented at national meetings including ASCO and SITC.

Published Articles (1)

Upper GI Cancer Updates: Perioperative Immunotherapy and New HER2-Directed Options

November 3, 2026

Perioperative immunotherapy is the new standard for resectable gastric and GEJ cancer, and zanidatamab offers a new HER2-directed option for metastatic disease, based on MATTERHORN, NeoSUMMIT-01, and HERIZON-GEA-01.